Format

Send to

Choose Destination
Int J Tuberc Lung Dis. 2014 Jun;18(6):737-43. doi: 10.5588/ijtld.13.0634.

Health care use and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea.

Author information

1
Department of Pulmonary and Critical Care Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.
2
Department of Internal Medicine, Konkuk University School of Medicine, Konkuk, Republic of Korea.
3
Department of Internal Medicine, Seoul St Mary's Hospital, Catholic University of Korea, Seoul, Republic of Korea.
4
Department of Internal Medicine, Yeouido St Mary's Hospital, Catholic University of Korea, Seoul, Republic of Korea.
5
Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
6
Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Republic of Korea.
7
Department of Internal Medicine, School of Medicine, Ewha Womans University, Seoul, Republic of Korea.
8
Department of Clinical Research Support, National Strategic Coordinating Center for Clinical Research, Seoul, Republic of Korea.
9
Department of Nursing, College of Medicine, Chosun University, Gwangju, Republic of Korea.

Abstract

BACKGROUND:

The prevalence and economic burden of chronic obstructive pulmonary disease (COPD) are increasing worldwide. However, little information is available concerning COPD-associated health care use and costs in Korea.

OBJECTIVE:

To analyse 1) health care use, medical costs and medication use in 2009, and 2) changes in costs and medication use over 5 years (2006-2010).

DESIGN:

Using the database of the Korean Health Insurance Review and Assessment Service, COPD patients were identified by searching on both ICD-10 codes and COPD medication. RESULTS A total of 192,496 COPD patients were identified in 2009. Total medical costs per person were US$2803 ± 3865; the average annual number of days of out-patient care and days of hospitalisation were respectively 40 ± 36 and 11 ± 33. Methylxanthine and systemic beta-agonists were the most frequently used drugs. However, the number of prescriptions for long-acting muscarinic antagonist increased rapidly. The total cost of COPD-related medications increased by 33.1% over 5 years.

CONCLUSION:

The present study provides new insight into health care use and the economic burden of COPD in Korea. Changing patterns of COPD-related medication use could help inform COPD management policies.

PMID:
24903947
DOI:
10.5588/ijtld.13.0634
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Ingenta plc
Loading ...
Support Center